Senior Life Sciences Moderator

Senior Life Sciences Moderator (Contract)

Location:

Atlanta, Boston, Chicago, Houston, Los Angeles, New York, San Francisco

Job Description

L.E.K. Consulting is one of the premier strategy consulting firms worldwide. At L.E.K., we are passionate about helping our clients succeed with breakthrough insights that drive real impact. Our clients view us as trusted partners that help address their most pressing challenges and biggest opportunities.

We bring together the rigor of data‑driven analysis with the creativity and curiosity of a collaborative team. By hiring exceptional people and fostering a culture of ownership, inclusion, and continuous learning, we develop leaders who thrive on challenge and bring energy and optimism to every engagement. Founded in 1983, L.E.K. employs more than 2,200 professionals across five continents, and is consistently recognized as one of the industry’s best firms to work for.

We are seeking a Senior Life Sciences Moderator to support high‑impact commercial and strategy engagements, with a focus on primary qualitative research. Insights from this research will be used for revenue forecasting and market assessment.

This role sits at the intersection of clinical insight generation and primary qualitative research support for commercial engagements. The successful candidate will lead end‑to‑end KOL workflows—from conducting interviews to synthesizing cross‑KOL insights that support forecasting analyses and broader case team hypothesis development.

The ideal candidate brings experience conducting high‑quality healthcare qualitative research and the ability to translate findings into clear themes related to market dynamics, adoption, and revenue drivers. Strong clinical fluency across multiple disease areas and the ability to quickly get up the curve in new indications are a plus. You will work across multiple concurrent engagements, partnering with consulting teams across geographies in a collaborative, globally integrated model.

This role is anticipated to be a 3–6 month contract engagement.

Team and interview engagements:

• Lead KOL interviews across a range of therapeutic areas (e.g., rare disease, immunology, neurology), establishing credibility quickly and probing effectively on clinical and treatment dynamics.
• Synthesize interview findings into clear, structured summaries that support revenue forecasts, including patient flow, adoption, pricing, and market access.
• Identify patterns and divergences across KOLs, highlighting key themes and findings for case teams and clients.
• Support case teams in organizing and synthesizing primary qualitative research findings for broader case team analyses.
• Manage multiple concurrent work streams (~2–3 projects), ensuring consistency and quality across engagements.
• Collaborate with global case teams to align research objectives, share findings, and support insight development.

Upstream design & quality:

• Review and refine KOL discussion guides to ensure alignment with core hypotheses and decision needs.
• Identify gaps, biases, or missed lines of inquiry in research design prior to fielding.
• Partner with teams to sharpen research objectives and ensure efficient use of KOL time.

Insight synthesis & deliverables:

• Create thematic summaries, key findings, and interview synthesis materials for use by consulting teams.
• Distill complex clinical perspectives into concise, structured research findings.
• Support development of interview synthesis slides and related research outputs.

Primary research & life sciences expertise:

• 3+ years of experience conducting qualitative research in life sciences consulting or pharma/biotech environments.
• Extensive experience conducting KOL interviews in high‑stakes commercial or strategy contexts.
• Strong clinical fluency across multiple therapeutic areas; ability to quickly get up the curve in new indications.
• Demonstrated ability to synthesize qualitative insights into clear themes, findings, and structured outputs.

Commercial & strategic acumen:

• Strong understanding of key market drivers (e.g., treatment paradigms, patient segmentation, access, pricing).
• Prefer…